Clinical Trials Insight: 700028493

Trial Profile

Clinical Trials Insight: 700028493

Phase of Trial: Phase I

Latest Information Update: 07 May 2008

At a glance

  • Drugs TC 6499 (Primary)
  • Indications Neuropathic pain
  • Focus Adverse reactions
  • Sponsors Targacept
  • Most Recent Events

    • 07 May 2008 Status changed from initiated to completed, according to a Targacept media release.
    • 15 Nov 2007 New trial record.
    • 09 Nov 2007 Dosing is expected to commence in the next few weeks.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top